BMS responds to media reports about UPSA

15 October 2018 - Deborah Wilkes

Bristol-Myers Squibb (BMS) says "no decisions" have been made about the future of its French consumer healthcare business UPSA. The company was responding to media reports that Germany's Stada Arzneimittel and three private-equity firms had made offers for the business.